解开密码:分子和遗传分析在彻底改变质母细胞瘤治疗中的作用
Moustafa A Mansour1, Ahmed M Kamer-Eldawla2, Reem W Malaeb3
1Department of Neurosurgery, Nasser Institute for Research and Treatment, Cairo, Egypt; Department of Neurology and Neurosurgery, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.
Cancer treatment and research communications
|February 22, 2025
概括
质母细胞瘤 (GBM) 是一种具有糟糕生存率的侵袭性脑癌. 新的疗法针对其分子亚型和瘤微环境,为改善患者结果提供希望.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 翻译医学是一种翻译医学.
背景情况:
- 质母细胞瘤 (GBM) 是最具攻击性的原发性脑癌,尽管采用多式疗法,但平均存活时间约为15个月.
- 瘤异质性和复杂的瘤微环境 (TME) 有助于治疗耐药性和不良预后.
- 分子分析的进步揭示了关键的遗传变化和亚型 (例如,EGFR放大,TP53变化),具有预后和治疗意义.
研究的目的:
- 审查 Glioblastoma (GBM) 治疗的不断变化的景观.
- 通过分子分析来强调个性化医学的重要性.
- 讨论新兴的治疗策略和需要创新的方法来克服治疗耐药性.
主要方法:
- 审查GBM的分子和遗传概况的近期进展.
- 对破坏异常信号通路的向疗法的分析 (例如RTK/RAS/PI3K,TP53).
- 探索新的治疗方法,包括免疫疗法,基于生物聚合物的间歇性疗法,聚焦超声波和纳米粒子药物输送.
主要成果:
- 分子分析已经确定了关键的GBM亚型和治疗点.
- 向疗法看起来很有前途,但由于抵抗机制而面临挑战.
- 免疫疗法和先进的药物输送系统等新兴策略旨在提高治疗疗效.
- 组合疗法和个性化医疗方法对于改善结果至关重要.
结论:
- 克服GBM的治疗耐药性需要创新的策略来解决瘤异质性和TME.
- 基于分子分析的个性化医疗对于量身定制GBM治疗至关重要.
- 对GBM生物学和新型治疗方法的持续研究为改善患者生存率和治疗结果提供了希望.
关键词:
基于生物聚合物的疗法.药物耐药性 药物耐药性 药物耐药性欧洲农业基准基金放大功率遗传变化是一种基因变化.质母细胞瘤 (GBM) 是一种免疫检查点抑制剂 免疫检查点抑制剂免疫疗法CAR T细胞疗法分子造型分析 (MOP) 是一种分子造型分析.个性化医疗是个性化的医疗.有针对性的治疗方法.瘤异质性 瘤异质性瘤微环境 (TME) 是指瘤的微环境.更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.8K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
